Daniel R. Faga
2016
In 2016, Daniel R. Faga earned a total compensation of $4.6M as Chief Business Officer at Spark Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $300,000 |
|---|---|
| Salary | $269,231 |
| Stock Awards | $4,052,876 |
| Other | $21,055 |
| Total | $4,643,162 |
Faga received $4.1M in stock awards, accounting for 87% of the total pay in 2016.
Faga also received $300K in non-equity incentive plan, $269.2K in salary and $21.1K in other compensation.
Rankings
In 2016, Daniel R. Faga's compensation ranked 1,801st out of 14,075 executives tracked by ExecPay. In other words, Faga earned more than 87.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,801 out of 14,075 | 87th |
Division Manufacturing | 614 out of 5,486 | 89th |
Major group Chemicals And Allied Products | 173 out of 1,900 | 91st |
Industry group Drugs | 121 out of 1,543 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 24 out of 287 | 92nd |
Source: SEC filing on April 21, 2017.
Faga's colleagues
We found four more compensation records of executives who worked with Daniel R. Faga at Spark Therapeutics in 2016.